Trials / Completed
CompletedNCT07179341
Survival Nomogram for Patients With Thymic Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Weijie Ye · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Background Thymic carcinoma (TC) is a rare and aggressive mediastinal malignancy with poor prognosis. Our study aimed to develop a nomogram to predict overall survival (OS) of TC patients. Method A total of 156 patients confirmed TC between 1996 and 2023 were selected from our database. They were divided into training cohort, validation cohort one and validation cohort two. A nomogram was constructed based on the risk factors affecting prognosis using a Cox proportional hazards regression model. The discrimination and calibration of the nomogram were evaluated by C-index, AUC and curve of calibration. The three cohorts were divided into low-risk and high-risk subgroups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Thymectomy for thymic carcinoma | Thymectomy for thymic cancer |
Timeline
- Start date
- 2024-07-09
- Primary completion
- 2025-07-01
- Completion
- 2025-08-01
- First posted
- 2025-09-17
- Last updated
- 2025-09-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07179341. Inclusion in this directory is not an endorsement.